<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T04:04:34Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:7955382" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:7955382</identifier>
        <datestamp>2021-03-17</datestamp>
        <setSpec>jaha</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">J Am Heart Assoc</journal-id>
              <journal-id journal-id-type="iso-abbrev">J Am Heart Assoc</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)2047-9980</journal-id>
              <journal-id journal-id-type="publisher-id">JAH3</journal-id>
              <journal-id journal-id-type="hwp">ahaoa</journal-id>
              <journal-title-group>
                <journal-title>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2047-9980</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC7955382</article-id>
              <article-id pub-id-type="pmcid">PMC7955382</article-id>
              <article-id pub-id-type="pmc-uid">7955382</article-id>
              <article-id pub-id-type="pmid">33289458</article-id>
              <article-id pub-id-type="pmid">33289458</article-id>
              <article-id pub-id-type="doi">10.1161/JAHA.119.015752</article-id>
              <article-id pub-id-type="publisher-id">JAH35769</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Original Research</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Research</subject>
                  <subj-group subj-group-type="heading">
                    <subject>Heart Failure</subject>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Ultrafiltration in Acute Heart Failure: Implications of Ejection Fraction and Early Response to Treatment From CARRESS‐HF</article-title>
                <alt-title alt-title-type="right-running-head">Ultrafiltration Decongestive Rate and LVEF</alt-title>
                <alt-title alt-title-type="left-running-head">Fudim et al</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="jah35769-cr-0001" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Fudim</surname>
                    <given-names>Marat</given-names>
                  </name>
                  <degrees>MD, MHS</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8671-7007</contrib-id>
                  <xref ref-type="aff" rid="jah35769-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="jah35769-aff-0002">
                    <sup>2</sup>
                  </xref>
                  <address>
                    <email>marat.fudim@gmail.com</email>
                  </address>
                </contrib>
                <contrib id="jah35769-cr-0002" contrib-type="author">
                  <name>
                    <surname>Brooksbank</surname>
                    <given-names>Jeremy</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref ref-type="aff" rid="jah35769-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jah35769-cr-0003" contrib-type="author">
                  <name>
                    <surname>Giczewska</surname>
                    <given-names>Anna</given-names>
                  </name>
                  <degrees>MS</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0533-2453</contrib-id>
                  <xref ref-type="aff" rid="jah35769-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah35769-cr-0004" contrib-type="author">
                  <name>
                    <surname>Greene</surname>
                    <given-names>Stephen J.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6912-7374</contrib-id>
                  <xref ref-type="aff" rid="jah35769-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="jah35769-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah35769-cr-0005" contrib-type="author">
                  <name>
                    <surname>Grodin</surname>
                    <given-names>Justin L.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2400-3196</contrib-id>
                  <xref ref-type="aff" rid="jah35769-aff-0003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jah35769-cr-0006" contrib-type="author">
                  <name>
                    <surname>Martens</surname>
                    <given-names>Pieter</given-names>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <xref ref-type="aff" rid="jah35769-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="jah35769-cr-0007" contrib-type="author">
                  <name>
                    <surname>Ter Maaten</surname>
                    <given-names>Jozine M.</given-names>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <xref ref-type="aff" rid="jah35769-aff-0004">
                    <sup>4</sup>
                  </xref>
                  <xref ref-type="aff" rid="jah35769-aff-0005">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib id="jah35769-cr-0008" contrib-type="author">
                  <name>
                    <surname>Sharma</surname>
                    <given-names>Abhinav</given-names>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2346-8330</contrib-id>
                  <xref ref-type="aff" rid="jah35769-aff-0004">
                    <sup>4</sup>
                  </xref>
                  <xref ref-type="aff" rid="jah35769-aff-0006">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib id="jah35769-cr-0009" contrib-type="author">
                  <name>
                    <surname>Verbrugge</surname>
                    <given-names>Frederik H.</given-names>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0599-9290</contrib-id>
                  <xref ref-type="aff" rid="jah35769-aff-0007">
                    <sup>7</sup>
                  </xref>
                  <xref ref-type="aff" rid="jah35769-aff-0008">
                    <sup>8</sup>
                  </xref>
                </contrib>
                <contrib id="jah35769-cr-0010" contrib-type="author">
                  <name>
                    <surname>Chakraborty</surname>
                    <given-names>Hrishikesh</given-names>
                  </name>
                  <degrees>DrPH</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9078-845X</contrib-id>
                  <xref ref-type="aff" rid="jah35769-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah35769-cr-0011" contrib-type="author">
                  <name>
                    <surname>Bart</surname>
                    <given-names>Bradley A.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0949-4567</contrib-id>
                  <xref ref-type="aff" rid="jah35769-aff-0009">
                    <sup>9</sup>
                  </xref>
                </contrib>
                <contrib id="jah35769-cr-0012" contrib-type="author">
                  <name>
                    <surname>Butler</surname>
                    <given-names>Javed</given-names>
                  </name>
                  <degrees>MD, MPH, MBA</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7683-4720</contrib-id>
                  <xref ref-type="aff" rid="jah35769-aff-0010">
                    <sup>10</sup>
                  </xref>
                </contrib>
                <contrib id="jah35769-cr-0013" contrib-type="author">
                  <name>
                    <surname>Hernandez</surname>
                    <given-names>Adrian F.</given-names>
                  </name>
                  <degrees>MD, MHS</degrees>
                  <xref ref-type="aff" rid="jah35769-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="jah35769-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah35769-cr-0014" contrib-type="author">
                  <name>
                    <surname>Felker</surname>
                    <given-names>G. Michael</given-names>
                  </name>
                  <degrees>MD, MHS</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5931-1239</contrib-id>
                  <xref ref-type="aff" rid="jah35769-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="jah35769-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah35769-cr-0015" contrib-type="author">
                  <name>
                    <surname>Mentz</surname>
                    <given-names>Robert J.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3222-1719</contrib-id>
                  <xref ref-type="aff" rid="jah35769-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="jah35769-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="jah35769-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">Division of Cardiology</named-content>
                <institution>Duke University Medical Center</institution>
                <city>Durham</city>
                <named-content content-type="country-part">NC</named-content>
              </aff>
              <aff id="jah35769-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <institution>Duke Clinical Research Institute</institution>
                <city>Durham</city>
                <named-content content-type="country-part">NC</named-content>
              </aff>
              <aff id="jah35769-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">Division of Cardiology</named-content>
                <institution>UT Southwestern</institution>
                <city>Dallas</city>
                <named-content content-type="country-part">TX</named-content>
              </aff>
              <aff id="jah35769-aff-0004">
                <label>
                  <sup>4</sup>
                </label>
                <named-content content-type="organisation-division">Department of Cardiology</named-content>
                <institution>Ziekenhuis Oost‐Limburg</institution>
                <city>Genk</city>
                <country country="BE">Belgium</country>
              </aff>
              <aff id="jah35769-aff-0005">
                <label>
                  <sup>5</sup>
                </label>
                <named-content content-type="organisation-division">Department of Cardiology</named-content>
                <institution>University Medical Center Groningen</institution>
                <institution>University of Groningen</institution>
                <city>Groningen</city>
                <country country="NL">The Netherlands</country>
              </aff>
              <aff id="jah35769-aff-0006">
                <label>
                  <sup>6</sup>
                </label>
                <named-content content-type="organisation-division">Division of Cardiology</named-content>
                <institution>McGill University Health Centre</institution>
                <city>Montreal</city>
                <named-content content-type="country-part">Quebec</named-content>
                <country country="CA">Canada</country>
              </aff>
              <aff id="jah35769-aff-0007">
                <label>
                  <sup>7</sup>
                </label>
                <named-content content-type="organisation-division">Department of Nephrology</named-content>
                <institution>Dialysis and Renal Transplantation, University Hospitals Leuven</institution>
                <city>Leuven</city>
                <country country="BE">Belgium</country>
              </aff>
              <aff id="jah35769-aff-0008">
                <label>
                  <sup>8</sup>
                </label>
                <named-content content-type="organisation-division">Biomedical Research Institute</named-content>
                <institution>Faculty of Medicine and Life Sciences, Hasselt University</institution>
                <city>Hasselt</city>
                <country country="BE">Belgium</country>
              </aff>
              <aff id="jah35769-aff-0009">
                <label>
                  <sup>9</sup>
                </label>
                <named-content content-type="organisation-division">Division of Cardiology</named-content>
                <institution>Hennepin County Medical Center</institution>
                <city>Minneapolis</city>
                <named-content content-type="country-part">MN</named-content>
              </aff>
              <aff id="jah35769-aff-0010">
                <label>
                  <sup>10</sup>
                </label>
                <institution>University of Mississippi School of Medicine</institution>
                <city>Jackson</city>
                <named-content content-type="country-part">MI</named-content>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label>
Correspondence to: Marat Fudim, MD, MHS, 2301 Erwin Road, 27713 Durham, NC, USA. E‐mail: <email>marat.fudim@gmail.com</email><break/></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>08</day>
                <month>12</month>
                <year>2020</year>
              </pub-date>
              <pub-date pub-type="collection">
                <day>15</day>
                <month>12</month>
                <year>2020</year>
              </pub-date>
              <volume>9</volume>
              <issue>24</issue>
              <issue-id pub-id-type="doi">10.1002/jah3.v9.24</issue-id>
              <elocation-id>e015752</elocation-id>
              <history>
                <date date-type="received">
                  <day>28</day>
                  <month>2</month>
                  <year>2020</year>
                </date>
                <date date-type="accepted">
                  <day>03</day>
                  <month>11</month>
                  <year>2020</year>
                </date>
              </history>
              <permissions>
                <!--<copyright-statement content-type="issue-copyright">Copyright &#x000a9; 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell<copyright-statement>-->
                <copyright-statement content-type="article-copyright">© 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.</copyright-statement>
                <license license-type="creativeCommonsBy-nc-nd">
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:JAH3-9-e015752.pdf"/>
              <abstract id="jah35769-abs-0001">
                <sec id="jah35769-sec-0001">
                  <title>Background</title>
                  <p>Ultrafiltration is not commonly used because of higher incidence of worsening renal function without improved decongestion. We examined differential outcomes of high versus low fluid removal and preserved versus reduced ejection fraction (EF) in CARRESS‐HF (Cardiorenal Rescue Study in Acute Decompensated Heart Failure).</p>
                </sec>
                <sec id="jah35769-sec-0002">
                  <title>Methods and Results</title>
                  <p>Baseline characteristics in the ultrafiltration arm were compared according to 24‐hour ultrafiltration‐based fluid removal above versus below the median. Patients were stratified by EF (≤40% or &gt;40%). We compared clinical parameters of clinical decongestion during the hospitalization based on initial (≤24 hours) response to ultrafiltration. Cox‐proportional hazards models were used to identify associations between fluid removal &lt;24 hours and composite of death, hospitalization, or unscheduled outpatient/emergency department visit during study follow‐up. The intention‐to‐treat analysis included 93 patients. Within 24 hours, median fluid removal was 1.89 L (Q1, Q3: 1.22, 3.16). The high fluid removal group had a greater urine output (9.08 versus 6.23 L, <italic>P</italic>=0.027) after 96 hours. Creatinine change from baseline to 96 hours was similar in both groups (0.10 mg/dL increase, <italic>P</italic>=0.610). The EF &gt;40% group demonstrated larger increases of change in creatinine (<italic>P</italic>=0.023) and aldosterone (<italic>P</italic>=0.038) from baseline to 96 hours. Among patients with EF &gt;40%, those with above median fluid removal (n=17) when compared with below median (n=17) had an increased rate of the combined end point (87.5% versus 47.1%, <italic>P</italic>=0.014).</p>
                </sec>
                <sec id="jah35769-sec-0003">
                  <title>Conclusions</title>
                  <p>In patients with acute heart failure, higher initial fluid removal with ultrafiltration had no association with worsening renal function. In patients with EF &gt;40%, ultrafiltration was associated with worsening renal function irrespective of fluid removal rate and higher initial fluid removal was associated with higher rates of adverse clinical outcomes, highlighting variable responses to decongestive therapy.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd id="jah35769-kwd-0001">congestion</kwd>
                <kwd id="jah35769-kwd-0002">heart failure</kwd>
                <kwd id="jah35769-kwd-0003">ultrafiltration</kwd>
              </kwd-group>
              <kwd-group kwd-group-type="subject-categories">
                <title>Subject Categories</title>
                <kwd>Heart Failure</kwd>
              </kwd-group>
              <counts>
                <fig-count count="0"/>
                <table-count count="5"/>
                <page-count count="7"/>
                <word-count count="4924"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>15 December 2020</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.9.7 mode:remove_FC converted:19.02.2021</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <p content-type="self-citation">
                <mixed-citation publication-type="journal" id="jah35769-cit-1001">(<source xml:lang="en">J Am Heart Assoc</source>. <year>2020</year>;<volume>9</volume>:<elocation-id>e015752</elocation-id>. DOI: <pub-id pub-id-type="doi">10.1161/JAHA.119.015752</pub-id>.)<pub-id pub-id-type="pmid">33289458</pub-id></mixed-citation>
              </p>
              <fn-group id="jah35769-ntgp-0001">
                <fn id="jah35769-note-0001">
                  <p>For Sources of Funding and Disclosures, see page 6.</p>
                </fn>
              </fn-group>
            </notes>
          </front>
          <body id="jah35769-body-0001">
            <def-list list-content="abbreviations" id="jah35769-lp-0001">
              <title>Nonstandard Abbreviations and Acronyms</title>
              <def-item>
                <term>AHF</term>
                <def>
                  <p>acute heart failure</p>
                </def>
              </def-item>
              <def-item>
                <term>CARRESS‐HF</term>
                <def>
                  <p>Cardiorenal Rescue Study in Acute Decompensated Heart Failure</p>
                </def>
              </def-item>
              <def-item>
                <term>WRF</term>
                <def>
                  <p>worsening renal function</p>
                </def>
              </def-item>
            </def-list>
            <p>
              <boxed-text position="anchor" content-type="box" id="jah35769-blkfxd-0001" orientation="portrait">
                <sec id="jah35769-sec-0005">
                  <title>Clinical Perspective</title>
                  <sec id="jah35769-sec-0006">
                    <title>What Is New?</title>
                    <p>
                      <list list-type="bullet" id="jah35769-list-0001">
                        <list-item>
                          <p>Higher initial fluid removal with ultrafiltration had no association with worsening renal function.</p>
                        </list-item>
                        <list-item>
                          <p>In patients with an ejection fraction &gt;40%, ultrafiltration was associated with worsening renal function irrespective of fluid removal.</p>
                        </list-item>
                        <list-item>
                          <p>In patients with an ejection fraction &gt;40%, higher initial fluid removal rate was associated with higher rates of adverse clinical outcomes.</p>
                        </list-item>
                      </list>
                    </p>
                  </sec>
                  <sec id="jah35769-sec-0007">
                    <title>What Are the Clinical Implications?</title>
                    <p>
                      <list list-type="bullet" id="jah35769-list-0002">
                        <list-item>
                          <p>We provide new insights into the mechanics of aggressive fluid removal in patients hospitalized for heart failure.</p>
                        </list-item>
                        <list-item>
                          <p>The work highlights the variable responses to decongestive therapy.</p>
                        </list-item>
                        <list-item>
                          <p>Heart failure with more preserved ejection fraction appears to be more prone to complications with aggressive fluid removal.</p>
                        </list-item>
                      </list>
                    </p>
                  </sec>
                </sec>
              </boxed-text>
            </p>
            <sec sec-type="opening-section" id="jah35769-sec-0008">
              <p>Diuretics improve symptoms in most patients with acute heart failure (AHF), yet more aggressive volume removal strategies such as ultrafiltration have not shown to be superior.<xref rid="jah35769-bib-0001" ref-type="ref"><sup>1</sup></xref>, <xref rid="jah35769-bib-0002" ref-type="ref"><sup>2</sup></xref>, <xref rid="jah35769-bib-0003" ref-type="ref"><sup>3</sup></xref> The UNLOAD (Ultrafiltration versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Congestive Heart Failure) and AVOID‐HF (Aquapheresis versus Intravenous Diuretics and Hospitalization for Heart Failure) trials showed that ultrafiltration resulted in more weight loss and net fluid loss as well as more favorable clinical outcomes compared with usual care.<xref rid="jah35769-bib-0002" ref-type="ref"><sup>2</sup></xref>, <xref rid="jah35769-bib-0003" ref-type="ref"><sup>3</sup></xref> Because a higher incidence of worsening renal function (WRF) without improved decongestion and increased adverse events related to vascular access complications were observed in CARRESS‐HF (Cardiorenal Rescue Study in Acute Decompensated Heart Failure), ultrafiltration is not commonly used.<xref rid="jah35769-bib-0001" ref-type="ref"><sup>1</sup></xref> We hypothesized that WRF in the ultrafiltration group was attributable to overaggressive volume removal in certain AHF subgroups. Ultrafiltration may have had different cardiorenal implications in patients with volume redistribution rather than volume overload as the predominant cause of decompensation because the mechanical removal of intravascular volume may lead to vascular underfilling overwhelming the capillary refill rate.<xref rid="jah35769-bib-0004" ref-type="ref"><sup>4</sup></xref>, <xref rid="jah35769-bib-0005" ref-type="ref"><sup>5</sup></xref>, <xref rid="jah35769-bib-0006" ref-type="ref"><sup>6</sup></xref> Patients with AHF and preserved ejection fraction (EF) may be particularly susceptible to rapid volume shifts, leading to worsened renal and cardiovascular outcomes.<xref rid="jah35769-bib-0007" ref-type="ref"><sup>7</sup></xref> The present analysis of CARRESS‐HF examines differential outcomes of high versus low fluid removal and preserved versus reduced EF.</p>
            </sec>
            <sec sec-type="methods" id="jah35769-sec-0009">
              <title>METHODS</title>
              <p>The data that support the findings of this study are available from the corresponding author upon reasonable request. CARRESS‐HF compared ultrafiltration at a constant rate of 200 mL/h with stepped pharmacological therapy among patients hospitalized for AHF who had already demonstrated WRF. Study groups experienced similar fluid removal and weight reduction, but creatinine increase was more frequent with ultrafiltration.<xref rid="jah35769-bib-0001" ref-type="ref"><sup>1</sup></xref> Although 200 mL/h was the target fluid removal rate, many patients did not achieve this rate.<xref rid="jah35769-bib-0008" ref-type="ref"><sup>8</sup></xref> For the present analysis, baseline characteristics in the ultrafiltration arm were compared according to 24‐hour ultrafiltration‐based fluid removal above versus below the median. Patients were stratified by EF (≤40% or &gt;40%). Ultrafiltration therapy was interrupted or discontinued for reasons such as hemodynamic instability, achievement of optimal volume status, evidence of volume depletion, increasing creatinine, and filter clotting or other vascular access dysfunction.<xref rid="jah35769-bib-0008" ref-type="ref"><sup>8</sup></xref> Outcomes of interest included net urine output, weight change, and change in serum creatinine, serum urea nitrogen (SUN), N‐terminal pro–brain natriuretic peptide, plasma renin activity, and aldosterone from baseline to 96 hours. Further, we evaluated the change in clinical congestion (jugular venous distension, edema, and orthopnea), days from randomization to discharge (named further length of stay), and composite outcome of death, hospitalization, or unscheduled outpatient/emergency department visit during study follow‐up (60 days).</p>
              <sec id="jah35769-sec-0010">
                <title>Statistical Analysis</title>
                <p>The intention‐to‐treat (ITT) population made the main cohort in our analysis. For the present analysis, patients were stratified by above and below median of fluid removal at 24 hours, and baseline characteristics were compared. Continuous variables were reported as median (25th percentile, 75th percentile) and compared using Wilcoxon rank‐sum tests. Categorical variables were presented as frequencies and percentages and compared using the chi‐square test or the Fisher's exact test when the frequencies were not sufficient.</p>
                <p>Wilcoxon rank‐sum test and Pearson chi‐square test or Fisher's exact test were also used to compare the changes from baseline to 96 hours of the outcomes of interest between our subgroups of interests. Our subgroups of interest were above and below median fluid removal at 24 hours, &gt;40% and ≤40% baseline EF, EF subgroups were further stratified by above and below median fluid removal at 24 hours.</p>
                <p>Unadjusted and adjusted Cox proportional hazards models were used to identify associations between fluid removal within the first 24 hours and composite. Age, sex, body mass index, creatinine, and EF were used as adjustment variables similarly to primary CARRESS‐HF publication.<xref rid="jah35769-bib-0001" ref-type="ref"><sup>1</sup></xref>
</p>
                <p>Additionally, a sensitivity analysis was included for the as‐treated population, where patients who were randomized to ultrafiltration but did not go on to receive therapy were excluded. <italic>P</italic> value &lt;0.05 was considered significant. All statistical analyses were performed using SAS (version 9.4).</p>
                <p>This primary study (CARRESS‐HF) was approved by the institutional board review and patients gave signed informed consent.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="jah35769-sec-0011">
              <title>RESULTS</title>
              <sec id="jah35769-sec-0012">
                <title>Intention‐to‐Treat Analysis</title>
                <p>The ITT analysis of CARRESS‐HF included 93 patients treated with ultrafiltration (49.7% of the original trial cohort). There were a total of 58 events over a median of 39 days of follow‐up. Within 24 hours, median fluid removal was 1.89 L (Q1, Q3: 1.22, 3.16). Baseline characteristics including age, sex, severity of congestion, race, relevant comorbidities, prior AHF hospitalizations, SUN and creatinine were similar in both the high (n=47) and low (n=46) fluid removal groups (all <italic>P</italic>&gt; 0.05) (Table <xref rid="jah35769-tbl-0001" ref-type="table">1</xref>). The high fluid removal group had a greater urine output (9.08 versus 6.23 L, <italic>P</italic>=0.027) and weight loss (13.89 versus 9.67 lbs, <italic>P</italic>=0.044) after 96 hours. Creatinine change from baseline to 96 hours was similar in both groups (0.10 mg/dL increase, <italic>P</italic>=0.610) (Table <xref rid="jah35769-tbl-0002" ref-type="table">2</xref>).</p>
                <table-wrap id="jah35769-tbl-0001" xml:lang="en" content-type="Table" orientation="portrait" position="float">
                  <label>Table 1</label>
                  <caption>
                    <p>Baseline Characteristics Stratified by the Fluid Removal in the First 24 hours (Above and Below Median)</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="top">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="top" rowspan="1" colspan="1"/>
                        <th align="center" valign="top" rowspan="1" colspan="1">Below Median<xref ref-type="fn" rid="jah35769-note-0002">*</xref> (N=46)</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">Above Median<xref ref-type="fn" rid="jah35769-note-0002">*</xref> (N=47)</th>
                        <th align="center" valign="top" rowspan="1" colspan="1"><italic>P</italic> Value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">Demographics</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Age in years, median (25th, 75th)</td>
                        <td align="left" rowspan="1" colspan="1">72.5 (61.0–79.0)</td>
                        <td align="left" rowspan="1" colspan="1">68 (61.0–76.0)</td>
                        <td align="left" rowspan="1" colspan="1">0.205</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Male sex, n/N (%)</td>
                        <td align="left" rowspan="1" colspan="1">34/46 (73.9%)</td>
                        <td align="left" rowspan="1" colspan="1">38/47 (80.9%)</td>
                        <td align="left" rowspan="1" colspan="1">0.424</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">White race, n/N (%)</td>
                        <td align="left" rowspan="1" colspan="1">34/46 (73.9%)</td>
                        <td align="left" rowspan="1" colspan="1">37/47 (78.7%)</td>
                        <td align="left" rowspan="1" colspan="1">0.585</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">Medications received before hospitalization</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Angiotensin‐converting enzyme inhibitor or angiotensin receptor blocker, n/N (%)</td>
                        <td align="left" rowspan="1" colspan="1">24/46 (52.2%)</td>
                        <td align="left" rowspan="1" colspan="1">27/47 (57.4%)</td>
                        <td align="left" rowspan="1" colspan="1">0.609</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Beta blocker, n/N (%)</td>
                        <td align="left" rowspan="1" colspan="1">35/46 (76.1%)</td>
                        <td align="left" rowspan="1" colspan="1">38/47 (80.9%)</td>
                        <td align="left" rowspan="1" colspan="1">0.576</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Aldosterone antagonist, n/N (%)</td>
                        <td align="left" rowspan="1" colspan="1">10/46 (21.7%)</td>
                        <td align="left" rowspan="1" colspan="1">11/47 (23.4%)</td>
                        <td align="left" rowspan="1" colspan="1">0.848</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Diuretic use, n/N (%)</td>
                        <td align="left" rowspan="1" colspan="1">40/46 (87.0%)</td>
                        <td align="left" rowspan="1" colspan="1">45/47 (95.7%)</td>
                        <td align="left" rowspan="1" colspan="1">0.158</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Furosemide equivalent diuretic dose, median (25th, 75th)</td>
                        <td align="left" rowspan="1" colspan="1">120.0 (40.0–180.0)</td>
                        <td align="left" rowspan="1" colspan="1">120.0 (80.0–240.0)</td>
                        <td align="left" rowspan="1" colspan="1">0.361</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">Medical history</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Ejection fraction, median (25th, 75th)</td>
                        <td align="left" rowspan="1" colspan="1">34.0, (20.0–55.0)</td>
                        <td align="left" rowspan="1" colspan="1">27.0 (20.0–45.0)</td>
                        <td align="left" rowspan="1" colspan="1">0.378</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Hospitalization for heart failure in previous y, n/N (%)</td>
                        <td align="left" rowspan="1" colspan="1">34/46 (73.9%)</td>
                        <td align="left" rowspan="1" colspan="1">35/46 (76.1%)</td>
                        <td align="left" rowspan="1" colspan="1">0.81</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Ischemia as cause of heart failure, n/N (%)</td>
                        <td align="left" rowspan="1" colspan="1">31/46 (67.4%)</td>
                        <td align="left" rowspan="1" colspan="1">34/47 (72.3%)</td>
                        <td align="left" rowspan="1" colspan="1">0.603</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Diabetes mellitus, n/N (%)</td>
                        <td align="left" rowspan="1" colspan="1">31/46 (67.4%)</td>
                        <td align="left" rowspan="1" colspan="1">29/47 (61.7%)</td>
                        <td align="left" rowspan="1" colspan="1">0.566</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Atrial fibrillation, n/N (%)</td>
                        <td align="left" rowspan="1" colspan="1">30/46 (65.2%)</td>
                        <td align="left" rowspan="1" colspan="1">23/47 (48.9%)</td>
                        <td align="left" rowspan="1" colspan="1">0.113</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Percutaneous transluminal coronary angioplasty, n/N (%)</td>
                        <td align="left" rowspan="1" colspan="1">12/46 (26.1%)</td>
                        <td align="left" rowspan="1" colspan="1">20/47 (42.6%)</td>
                        <td align="left" rowspan="1" colspan="1">0.095</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Coronary artery bypass grafting, n/N (%)</td>
                        <td align="left" rowspan="1" colspan="1">15/46 (32.6%)</td>
                        <td align="left" rowspan="1" colspan="1">20/47 (42.6%)</td>
                        <td align="left" rowspan="1" colspan="1">0.322</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Sustained ventricular tachycardia or ventricular fibrillation arrhythmia, n/N (%)</td>
                        <td align="left" rowspan="1" colspan="1">4/46 (8.7%)</td>
                        <td align="left" rowspan="1" colspan="1">5/47 (10.6%)</td>
                        <td align="left" rowspan="1" colspan="1">1.000</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Aortic or mitral valve disease, n/N (%)</td>
                        <td align="left" rowspan="1" colspan="1">15/44 (34.1%)</td>
                        <td align="left" rowspan="1" colspan="1">21/46 (45.7%)</td>
                        <td align="left" rowspan="1" colspan="1">0.263</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Weight, lbs, median, (25th, 75th)</td>
                        <td align="left" rowspan="1" colspan="1">206.6, (179.5–265.4)</td>
                        <td align="left" rowspan="1" colspan="1">207.7 (162.5–264.3)</td>
                        <td align="left" rowspan="1" colspan="1">0.707</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Peripheral edema (moderate +), n/N (%)</td>
                        <td align="left" rowspan="1" colspan="1">41/46 (89.1%)</td>
                        <td align="left" rowspan="1" colspan="1">39/47 (83.0%)</td>
                        <td align="left" rowspan="1" colspan="1">0.392</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Rales, n/N (%)</td>
                        <td align="left" rowspan="1" colspan="1">26/46 (56.5%)</td>
                        <td align="left" rowspan="1" colspan="1">28/47 (59.6%)</td>
                        <td align="left" rowspan="1" colspan="1">0.766</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Orthopnea (2 pillows +), n/N (%)</td>
                        <td align="left" rowspan="1" colspan="1">36/45 (80.0%)</td>
                        <td align="left" rowspan="1" colspan="1">39/43 (90.7%)</td>
                        <td align="left" rowspan="1" colspan="1">0.157</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Dyspnea visual analog scale, median, (25th, 75th)</td>
                        <td align="left" rowspan="1" colspan="1">46.5 (28.0–70.0)</td>
                        <td align="left" rowspan="1" colspan="1">54.0 (30.0–76.0)</td>
                        <td align="left" rowspan="1" colspan="1">0.282</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">New York Heart Association class (III, IV), n/N (%)</td>
                        <td align="left" rowspan="1" colspan="1">45/45 (100.0%)</td>
                        <td align="left" rowspan="1" colspan="1">45/45 (100.0%)</td>
                        <td align="left" rowspan="1" colspan="1">‐</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">Biomarkers</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Creatinine, mg/dL, median, (25th, 75th)</td>
                        <td align="left" rowspan="1" colspan="1">2. (1.6–2.4)</td>
                        <td align="left" rowspan="1" colspan="1">1.9 (1.5–2.4)</td>
                        <td align="left" rowspan="1" colspan="1">0.737</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">N‐terminal pro–brain natriuretic peptide, pg/mL, median,</td>
                        <td align="left" rowspan="1" colspan="1">5702.0 (3011.0–11701.0)</td>
                        <td align="left" rowspan="1" colspan="1">4013 (2236.0–9950.0)</td>
                        <td align="left" rowspan="1" colspan="1">0.259</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Plasma renin activity, median, (25th, 75th)</td>
                        <td align="left" rowspan="1" colspan="1">4.9 (1.8–17.0)</td>
                        <td align="left" rowspan="1" colspan="1">9.3 (2.9–17.1)</td>
                        <td align="left" rowspan="1" colspan="1">0.256</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Aldosterone, median, (25th, 75th)</td>
                        <td align="left" rowspan="1" colspan="1">213.6 (124.4–419.9)</td>
                        <td align="left" rowspan="1" colspan="1">216.4 (151–416.3)</td>
                        <td align="left" rowspan="1" colspan="1">0.718</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jah35769-ntgp-0002">
                    <fn id="jah35769-note-0002">
                      <label>*</label>
                      <p>Median for patients with ultrafiltration is equal to 1.89 L. Wilcoxon rank‐sum test was used to compare differences between continuous variables and chi‐square test or Fisher's exact test were used to compare differences between categorical variables.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
                <table-wrap id="jah35769-tbl-0002" xml:lang="en" content-type="Table" orientation="portrait" position="float">
                  <label>Table 2</label>
                  <caption>
                    <p>Association With Outcomes Stratified by Fluid Removal in the First 24 Hours (Above and Below Median) and Ejection Fraction (≤40% Versus &gt;40%)</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="top">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="2" valign="top" colspan="1"/>
                        <th align="center" colspan="3" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Volume Removed in First 24 h</th>
                        <th align="center" colspan="3" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Baseline Ejection Fraction</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="center" valign="top" rowspan="1" colspan="1">Low Volume Removal (n=46)</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">High Volume Removal (n=47)</th>
                        <th align="center" valign="top" rowspan="1" colspan="1"><italic>P</italic> Value<xref ref-type="fn" rid="jah35769-note-0005">*</xref>
</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">EF ≤40% (n=59)</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">EF &gt;40% (n=35)</th>
                        <th align="center" valign="top" rowspan="1" colspan="1"><italic>P</italic> Value<xref ref-type="fn" rid="jah35769-note-0005">*</xref>
</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Net urine output at 96 h, L</td>
                        <td align="left" rowspan="1" colspan="1">6.23 (3.87, 9.87)</td>
                        <td align="left" rowspan="1" colspan="1">9.08 (5.91,10.52)</td>
                        <td align="left" rowspan="1" colspan="1">0.027</td>
                        <td align="left" rowspan="1" colspan="1">6.98 (4.09, 10.3)</td>
                        <td align="left" rowspan="1" colspan="1">7.28 (4.63,10.6)</td>
                        <td align="left" rowspan="1" colspan="1">0.420</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">∆ Weight, lbs</td>
                        <td align="left" rowspan="1" colspan="1">↓9.67 (−13.60, −5.73)</td>
                        <td align="left" rowspan="1" colspan="1">↓13.89 (−22.71, −7.28)</td>
                        <td align="left" rowspan="1" colspan="1">0.044</td>
                        <td align="left" rowspan="1" colspan="1">↓11.55 (−15.40, −5.95)</td>
                        <td align="left" rowspan="1" colspan="1">↓11.68 (−18.30, −7.05)</td>
                        <td align="left" rowspan="1" colspan="1">0.690</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">∆ Creatinine, mg/dL</td>
                        <td align="left" rowspan="1" colspan="1">↑0.10 (−0.12, 0.53)</td>
                        <td align="left" rowspan="1" colspan="1">↑0.10 (−0.31, 0.57)</td>
                        <td align="left" rowspan="1" colspan="1">0.601</td>
                        <td align="left" rowspan="1" colspan="1">↓0.04 (−0.31, 0.42)</td>
                        <td align="left" rowspan="1" colspan="1">↑0.19 (−0.01, 0.96)</td>
                        <td align="left" rowspan="1" colspan="1">0.023</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">∆ Serum urea nitrogen</td>
                        <td align="left" rowspan="1" colspan="1">↑9.50 (−2.00, 22.00)</td>
                        <td align="left" rowspan="1" colspan="1">↑12.00 (−3.00, 24.00)</td>
                        <td align="left" rowspan="1" colspan="1">0.756</td>
                        <td align="left" rowspan="1" colspan="1">↑4.00 (−3.00, 19.00)</td>
                        <td align="left" rowspan="1" colspan="1">↑17.50 (1.00–32.00)</td>
                        <td align="left" rowspan="1" colspan="1">0.029</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">∆N‐terminal pro–brain natriuretic peptide, pg/mL</td>
                        <td align="left" rowspan="1" colspan="1">↓273.70 (−2149.00, 1172.00)</td>
                        <td align="left" rowspan="1" colspan="1">↓656.00 (−1516.00, 54.30)</td>
                        <td align="left" rowspan="1" colspan="1">0.331</td>
                        <td align="left" rowspan="1" colspan="1">↓836.00 (−2748.00, 30.30)</td>
                        <td align="left" rowspan="1" colspan="1">↓108.40 (−1046.00, 266.00)</td>
                        <td align="left" rowspan="1" colspan="1">0.068</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">∆ Plasma renin activity, ng/mL/hr</td>
                        <td align="left" rowspan="1" colspan="1">↑1.68 (−0.53, 10.37)</td>
                        <td align="left" rowspan="1" colspan="1">↑8.66 (−0.09, 19.8)</td>
                        <td align="left" rowspan="1" colspan="1">0.134</td>
                        <td align="left" rowspan="1" colspan="1">↑2.21 (−0.18, 13.49)</td>
                        <td align="left" rowspan="1" colspan="1">↑6.06 (0.16, 14.01)</td>
                        <td align="left" rowspan="1" colspan="1">0.537</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">∆ Aldosterone, ng/dL</td>
                        <td align="left" rowspan="1" colspan="1">↓0.55 (−98.07, 47.5)</td>
                        <td align="left" rowspan="1" colspan="1">↓23.54 (−90.84, 161.91)</td>
                        <td align="left" rowspan="1" colspan="1">0.780</td>
                        <td align="left" rowspan="1" colspan="1">↓31.76 (−199.90, 50.75)</td>
                        <td align="left" rowspan="1" colspan="1">↑2.87 (−35.58, 108.27)</td>
                        <td align="left" rowspan="1" colspan="1">0.038</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Congestion at 96 h</td>
                        <td align="left" rowspan="1" colspan="1">39/43 (90.7%)</td>
                        <td align="left" rowspan="1" colspan="1">35/39 (89.7%)</td>
                        <td align="left" rowspan="1" colspan="1">1.000</td>
                        <td align="left" rowspan="1" colspan="1">45/50 (90%)</td>
                        <td align="left" rowspan="1" colspan="1">29/32 (90.6%)</td>
                        <td align="left" rowspan="1" colspan="1">1.000</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Length of stay, d<xref ref-type="fn" rid="jah35769-note-0006"><sup>†</sup></xref>
</td>
                        <td align="left" rowspan="1" colspan="1">8 (6, 13)</td>
                        <td align="left" rowspan="1" colspan="1">6 (4, 9)</td>
                        <td align="left" rowspan="1" colspan="1">0.010</td>
                        <td align="left" rowspan="1" colspan="1">7 (5, 11)</td>
                        <td align="left" rowspan="1" colspan="1">7 (5, 13)</td>
                        <td align="left" rowspan="1" colspan="1">0.624</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Death, hospital, or emergency department/urgent care</td>
                        <td align="left" rowspan="1" colspan="1">28/46 (60.9%)</td>
                        <td align="left" rowspan="1" colspan="1">34/46 (73.9%)</td>
                        <td align="left" rowspan="1" colspan="1">0.182</td>
                        <td align="left" rowspan="1" colspan="1">40/59 (67.8%)</td>
                        <td align="left" rowspan="1" colspan="1">22/34 (64.7%)</td>
                        <td align="left" rowspan="1" colspan="1">0.761</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jah35769-ntgp-0003">
                    <fn id="jah35769-note-0004">
                      <p>∆–change from baseline to 96 hours. EF indicates ejection fraction.</p>
                    </fn>
                    <fn id="jah35769-note-0005">
                      <label>*</label>
                      <p><italic>P</italic> value represents Median for patients with ultrafiltration is equal 1.89L. Wilcoxon rank‐sum test or Pearson chi‐square test or Fisher's exact test.</p>
                    </fn>
                    <fn id="jah35769-note-0006">
                      <label>
                        <sup>†</sup>
                      </label>
                      <p>days from randomization to discharge.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
                <p>Patients with EF ≤40% (n=59) versus &gt; 40% (n=35) had a median of 2.28 L (Q1, Q3: 1.22, 3.29) versus 1.75 L (Q1, Q3: 1.14, 2.80) fluid removed in the first 24 hours. Weight change and urine output at 96 hours were similar regardless of EF. The EF &gt;40% group demonstrated larger increases in creatinine (<italic>P</italic>=0.023), SUN (<italic>P</italic>=0.029), and aldosterone (<italic>P</italic>=0.038) at 96 hours (Table <xref rid="jah35769-tbl-0002" ref-type="table">2</xref>). Among patients with EF &gt;40%, those with above median fluid removal (n=17) when compared with below median (n=17) had an increased rate of death, hospitalization, or unscheduled outpatient/emergency department visit during study follow‐up (87.5% versus 47.1%, <italic>P</italic>=0.014) (Table <xref rid="jah35769-tbl-0003" ref-type="table">3</xref>). The hazard ratio (HR) was 2.45 (95% CI, 1.00–6.00; <italic>P</italic>=0.05), but risk was attenuated after adjustment (HR, 2.00; 95% CI, 0.71–5.65; <italic>P</italic>=0.19) (Table <xref rid="jah35769-tbl-0004" ref-type="table">4</xref>). There was no difference in renal function (<italic>P</italic>=0.771 for EF ≤40% and <italic>P</italic>=0.767 for EF &gt; 40%.</p>
                <table-wrap id="jah35769-tbl-0003" xml:lang="en" content-type="Table" orientation="portrait" position="float">
                  <label>Table 3</label>
                  <caption>
                    <p>Association With Outcomes Stratified by Ejection Fraction (≤40% Versus &gt;40%)</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="top">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="2" valign="top" colspan="1"/>
                        <th align="center" colspan="3" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Ejection Fraction ≤40% Volume Removed in the First 24 h</th>
                        <th align="center" colspan="3" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Ejection Fraction &gt;40% Volume Removed in the First 24 h</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="center" valign="top" rowspan="1" colspan="1">Low Volume Removal (n=29)</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">High Volume Removal (n=30)</th>
                        <th align="center" valign="top" rowspan="1" colspan="1"><italic>P</italic> Value<xref ref-type="fn" rid="jah35769-note-0008">*</xref>
</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">Low Volume Removal (n=17)</th>
                        <th align="center" valign="top" rowspan="1" colspan="1">High Volume Removal (n=17)</th>
                        <th align="center" valign="top" rowspan="1" colspan="1"><italic>P</italic> Value<xref ref-type="fn" rid="jah35769-note-0008">*</xref>
</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Net urine output at 96 h, L</td>
                        <td align="char" char="(" rowspan="1" colspan="1">6.00 (2.60, 8.07)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">8.90 (5.93,12.07)</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.031</td>
                        <td align="char" char="(" rowspan="1" colspan="1">7.12 (5.44, 11.06)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">8.62 (4.35,10.46)</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.917</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">∆ Weight, lbs</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↓8.82 (−12.57, −5.29)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↓13.89 (−22.93, −9.92)</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.014</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↓11.68 (−14.90, −7.80)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↓11.17 (−22.49, −7.05)</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.858</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">∆ Creatinine, mg/dL</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↓0.08 (−0.19, 0.42)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↑0.06 (−0.46, 0.37)</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.771</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↑0.19 (0.02, 1.24)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↑0.20 (−0.08, 0.86)</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.767</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">∆ Serum urea nitrogen</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↑2.00 (−2.00, 14.80)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↑4.50 (−9.00, 21.57)</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.732</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↑18.00 (9.00, 31.00)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↑17.00 (0.00, 32.00)</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.547</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">∆N‐terminal pro–brain natriuretic peptide, pg/mL</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↓677.50 (−2748.00, 1325.50)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↓836.00 (−2765.00, −291.00)</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.643</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↓435.90 (−1202.00, 359.50)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↓54.30 (−942.90, 266.00)</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.635</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">∆ Plasma renin activity, ng/mL/hr</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↑1.40 (−0.78, 5.36)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↑8.66 (−0.15, 22.36)</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.187</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↑3.19 (−0.76, 16.24)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↑6.27 (1.17, 13.09)</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.707</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">∆ Aldosterone, ng/dL</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↓29.05 (−229.60, 44.40)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↓34.46 (−114.9, 143.03)</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.535</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↓0.55 (−58.88, 53.09)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">↑57.93 (−35.58, 379.10)</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.149</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Congestion at 96 h</td>
                        <td align="char" char="(" rowspan="1" colspan="1">24/26 (92.3%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">21/24 (87.5%)</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.661</td>
                        <td align="char" char="(" rowspan="1" colspan="1">16/17 (94.1%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">13/15 (86.7%)</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.589</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Length of stay, days<xref ref-type="fn" rid="jah35769-note-0009"><sup>†</sup></xref>
</td>
                        <td align="char" char="(" rowspan="1" colspan="1">8 (6, 11)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">6 (4, 10)</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.072</td>
                        <td align="char" char="(" rowspan="1" colspan="1">11 (7, 13)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">5 (4, 8)</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.008</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Death, hospital, or emergency department/urgent care</td>
                        <td align="char" char="(" rowspan="1" colspan="1">19/29 (65.5%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">21/30 (70.0%)</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.713</td>
                        <td align="char" char="(" rowspan="1" colspan="1">8/17 (47.1%)</td>
                        <td align="char" char="(" rowspan="1" colspan="1">14/16 (87.5%)</td>
                        <td align="char" char="." rowspan="1" colspan="1">0.014</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jah35769-ntgp-0004">
                    <fn id="jah35769-note-0007">
                      <p>∆–change from baseline to 96 hours. Groups are further stratified by fluid removal in the first 24 hours (above and below median).</p>
                    </fn>
                    <fn id="jah35769-note-0008">
                      <label>*</label>
                      <p><italic>P</italic> value represents Wilcoxon rank‐sum test or Pearson chi‐square test or Fisher's exact test.</p>
                    </fn>
                    <fn id="jah35769-note-0009">
                      <label>
                        <sup>†</sup>
                      </label>
                      <p>days from randomization to discharge.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
                <table-wrap id="jah35769-tbl-0004" xml:lang="en" content-type="Table" orientation="portrait" position="float">
                  <label>Table 4</label>
                  <caption>
                    <p>Hazard Ratio for Low and High Fluid Removal in 24 hours With Separation for Type of Treatment and Reduced and Preserved Ejection Fraction—Intention‐to‐Treat Population</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="bottom">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="3" valign="bottom" colspan="1">Outcome</th>
                        <th align="left" colspan="4" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">LVEF ≤40</th>
                        <th align="left" colspan="4" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">LVEF &gt;40</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Unadjusted</th>
                        <th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Adjusted<xref ref-type="fn" rid="jah35769-note-0011">*</xref>
</th>
                        <th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Unadjusted</th>
                        <th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Adjusted</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="bottom" rowspan="1" colspan="1">HR (95% CI)</th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1"><italic>P</italic> Value</th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1">HR (95% CI)</th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1"><italic>P</italic> Value</th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1">HR (95% CI)</th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1"><italic>P</italic> Value</th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1">HR (95% CI)</th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1"><italic>P</italic> Value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" colspan="9" rowspan="1">Ultrafiltration</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Time to first of death, rehospitalization, unscheduled outpatient/emergency department visit</td>
                        <td align="left" rowspan="1" colspan="1">0.94 (0.50–1.77)</td>
                        <td align="left" rowspan="1" colspan="1">0.854</td>
                        <td align="left" rowspan="1" colspan="1">1.26 (0.62–2.56)</td>
                        <td align="left" rowspan="1" colspan="1">0.524</td>
                        <td align="left" rowspan="1" colspan="1">2.45 (1.00–6.00)</td>
                        <td align="left" rowspan="1" colspan="1">0.050</td>
                        <td align="left" rowspan="1" colspan="1">2.00 (0.71–5.65)</td>
                        <td align="left" rowspan="1" colspan="1">0.192</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jah35769-ntgp-0005">
                    <fn id="jah35769-note-0010">
                      <p>HR indicates hazard ratio; and LVEF, left ventricular ejection fraction.</p>
                    </fn>
                    <fn id="jah35769-note-0011">
                      <label>*</label>
                      <p>Adjustment covariates include age, sex, baseline body mass index, baseline creatinine, and baseline LVEF. Reference groups: female and below median in total fluid removal in the first 24 hours.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
              </sec>
              <sec id="jah35769-sec-0013">
                <title>Sensitivity Analysis—as‐Treated Analysis</title>
                <p>For the as‐treated analysis 8 patients were removed from the original cohort to make a total of 86 patients treated with ultrafiltration (46.0% of the total CARRESS‐HF trial cohort). Within 24 hours, median fluid removal was 2.11 L (Q1, Q3: 1.31, 3.34). Baseline characteristics including age, sex, severity of congestion, race, relevant comorbidities, prior AHF hospitalizations, SUN, and creatinine were similar in both the high (n=45) and low (n=41) fluid removal groups (all <italic>P</italic>&gt;0.05). The high fluid removal group had a trend toward greater urine output (9.08 versus 6.85 L, <italic>P</italic>=0.101) and weight loss (13.89 versus 10.80 lbs, <italic>P</italic>=0.094) after 96 hours. Creatinine change from baseline to 96 hours was similar in both groups (0.10 versus 0.13 mg/dL increase, <italic>P</italic>=0.538) (Table S1) .</p>
                <p>Patients with EF ≤40% (n=55) versus &gt;40% (n=31) had a median of 2.30 L (Q1, Q3: 1.33, 3.34) versus 1.73 L (Q1, Q3: 1.14, 3.34) fluid removed in the first 24 hours. Weight change from baseline to 96 hours and urine output at 96 hours were similar regardless of EF group <italic>P</italic>&gt;0.05 for both outcomes). The EF &gt;40% group demonstrated larger increases in creatinine (<italic>P</italic>=0.020), SUN (<italic>P</italic>=0.060), and aldosterone (<italic>P</italic>=0.036) at 96 hours (Table S1). Among patients with EF &gt;40%, those with above median fluid removal (n=15) when compared with below median (n=16) had a trend toward increased rate of death, hospitalization, or unscheduled emergency department visit during study follow‐up (85.7% versus 50.0%, <italic>P</italic>=0.058). Among patients with EF ≤40%, those with high volume removal had a similar rate of death, hospitalization, or unscheduled emergency department visit during follow‐up (70.0% versus 65.5%, <italic>P</italic>=0.713) (Table S2).</p>
                <p>The unadjusted HR was 2.12 (95% CI, 0.84–5.36; <italic>P</italic>=0.11) and after adjustment HR was 1.83 (95% CI, 0.63–5.33; <italic>P</italic>=0.27) (Table <xref rid="jah35769-tbl-0005" ref-type="table">5</xref>). There was no significant change in renal function in either group.</p>
                <table-wrap id="jah35769-tbl-0005" xml:lang="en" content-type="Table" orientation="portrait" position="float">
                  <label>Table 5</label>
                  <caption>
                    <p>Hazard Ratio for Low and High Fluid Removal in 24 hours With Separation for Type of Treatment and Reduced and Preserved Ejection Fraction—as‐Treated Population</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="bottom">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="3" valign="bottom" colspan="1">Outcome</th>
                        <th align="center" colspan="4" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">LVEF ≤40</th>
                        <th align="center" colspan="4" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">LVEF &gt;40</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="center" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Unadjusted</th>
                        <th align="center" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Adjusted<xref ref-type="fn" rid="jah35769-note-0013">*</xref>
</th>
                        <th align="center" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Unadjusted</th>
                        <th align="center" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Adjusted<xref ref-type="fn" rid="jah35769-note-0013">*</xref>
</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="center" valign="bottom" rowspan="1" colspan="1">HR (95% CI)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1"><italic>P</italic> Value</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">HR (95% CI)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1"><italic>P</italic> Value</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">HR (95% CI)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1"><italic>P</italic> Value</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">HR (95% CI)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1"><italic>P</italic> Value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" colspan="9" rowspan="1">Ultrafiltration</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Time to first of death, rehospitalization, unscheduled outpatient/emergency department visit</td>
                        <td align="left" rowspan="1" colspan="1">1.10 (0.57–2.11)</td>
                        <td align="left" rowspan="1" colspan="1">0.777</td>
                        <td align="left" rowspan="1" colspan="1">1.35 (0.66–2.75)</td>
                        <td align="left" rowspan="1" colspan="1">0.409</td>
                        <td align="left" rowspan="1" colspan="1">2.12 (0.84–5.36)</td>
                        <td align="left" rowspan="1" colspan="1">0.111</td>
                        <td align="left" rowspan="1" colspan="1">1.83 (0.63–5.33)</td>
                        <td align="left" rowspan="1" colspan="1">0.269</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jah35769-ntgp-0006">
                    <fn id="jah35769-note-0012">
                      <p>HR indicates hazard ratio; and LVEF, left ventricular ejection fraction.</p>
                    </fn>
                    <fn id="jah35769-note-0013">
                      <label>*</label>
                      <p>Adjustment covariates include age, sex, baseline body mass index, baseline creatinine, baseline LVEF. Reference groups: female and below median in total fluid removal in the first 24 hours.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
              </sec>
            </sec>
            <sec sec-type="discussion" id="jah35769-sec-0014">
              <title>DISCUSSION</title>
              <p>In this clinical trial population of patients with AHF treated with ultrafiltration, the main findings in the ITT analysis were (1) higher initial volume removal was associated with greater weight loss and urine output without WRF; (2) patients with EF &gt;40% were most likely to develop WRF; and (3) patients with EF &gt;40% receiving high initial volume removal were at increased risk for subsequent adverse clinical outcomes. In the as‐treated analysis, the observed clinical outcomes were attenuated, with the exception of the association between EF &gt;40% and a higher risk of WRF. This first multicenter analysis comparing the response to ultrafiltration among patients with heart failure with preserved EF versus heart failure with reduced EF identified a high‐risk cohort for ultrafiltration therapy and supports a differential congestive physiology between AHF subgroups.</p>
              <p>Similar to prior studies, rapid intravascular fluid removal also increased urine production.<xref rid="jah35769-bib-0009" ref-type="ref"><sup>9</sup></xref> The current results from CARRESS‐HF build on prior work showing that in AHF urine output increase was independent of cardiac output and not seen in patients without congestion, which suggests an important role of venous congestion removal on the glomerular filtration rate.<xref rid="jah35769-bib-0009" ref-type="ref"><sup>9</sup></xref> Patients with AHF may experience congestion and resultant cardiovascular decompensation via volume overload, redistribution, or a combination thereof.<xref rid="jah35769-bib-0010" ref-type="ref"><sup>10</sup></xref> In other words, volume overload is not always the underlying etiology of cardiovascular decompensation but can be the results of a change in vascular capacitance.<xref rid="jah35769-bib-0004" ref-type="ref"><sup>4</sup></xref>, <xref rid="jah35769-bib-0011" ref-type="ref"><sup>11</sup></xref>, <xref rid="jah35769-bib-0012" ref-type="ref"><sup>12</sup></xref> In particular, patients with HFpEF are suggested to be especially fluid sensitive, given increased vascular stiffness leading to more interstitial volume expansion with less intravascular fluid retention and may decompensate with the addition of small volume fluid than patients with heart failure with reduced EF.<xref rid="jah35769-bib-0007" ref-type="ref"><sup>7</sup></xref> In AHF, the result may be a decreased fluid uptake from the interstitium, leading to WRF in the setting of aggressive fluid removal regardless of method. Fixed fluid removal with ultrafiltration in CARRESS‐HF may thus have led to intravascular hypovolemia by exceeding the capillary refill rate. This analysis suggests that patients with HFpEF are more sensitive to up‐front volume shifts. Further, WRF during decongestion is not necessarily a marker of renal injury but could be a marker of appropriate decongestion. Nevertheless, a change in creatinine was the primary end point in the CARRESS‐HF and remains an important clinical surrogate guiding volume removal.</p>
            </sec>
            <sec id="jah35769-sec-0015">
              <title>LIMITATIONS</title>
              <p>These results must be interpreted in the context of several limitations. First, this is a retrospective analysis in which we evaluated differing effects of ultrafiltration therapy in the first 24 hours. We did not extend our analysis to ultrafiltration therapy &gt;24 hours as many patients in CARRESS‐HF had ultrafiltration discontinued in subsequent days for various reasons. Notably, a 20% crossover rate limited ITT analysis. The sensitivity analysis using the as‐treated, excluding 8 patients who did not receive ultrafiltration upon randomization limited some of the findings previously seen with the ITT analysis. This underlines the limited samples size of analysis and demands additional verification in a larger trial of ultrafiltration such as the AVOID‐HF trial.<xref rid="jah35769-bib-0002" ref-type="ref"><sup>2</sup></xref>
</p>
            </sec>
            <sec sec-type="conclusions" id="jah35769-sec-0016">
              <title>CONCLUSIONS</title>
              <p>In the ITT analysis of patients with AHF and cardiorenal syndrome, higher initial fluid removal with ultrafiltration had no association with WRF. In patients with an EF &gt;40%, ultrafiltration was associated with WRF irrespective of fluid removal. Further, higher initial fluid removal rate was associated with higher rates of adverse clinical outcomes, highlighting variable responses to decongestive therapy.</p>
            </sec>
            <sec id="jah35769-sec-0017">
              <title>Sources of Funding</title>
              <p>None.</p>
            </sec>
            <sec sec-type="COI-statement" id="jah35769-sec-0018">
              <title>Disclosures</title>
              <p>Dr. Fudim is supported by an American Heart Association Grant, 17MCPRP33460225; he consults for Coridea, AxonTherapies, Galvani, and Daxor. Dr. Greene has received research support from a Heart Failure Society of America/ Emergency Medicine Foundation Acute Heart Failure Young Investigator Award funded by Novartis, Amgen, Bristol‐Myers Squibb and Novartis; and serves on an advisory board for Amgen. Dr. Sharma has received research support from the Fonds de la recherche en santé du Québec (FRSQ)‐Junior 1, Jean Roy award in Cardiology (McGill University), Akcea, Pharma, Solutions, Alberta Innovates Health Solutions, Bayer‐Canadian Cardiovascular Society, Boehringer‐Ingelheim, Roche Diagnostics, and Takeda. Dr. Verbrugge was supported by a Fellowship of the Belgian American Educational Foundation. Dr. Martens has received consultancy fees from Astra‐Zeneca, Bayer, Boehringer‐Ingelheim, Novartis, and Vifor Pharma and an unrestricted research grant from Vifor Pharma. Dr. Grodin receives research support from the Texas Health Resources Clinical Scholars fund and has received consultancy fees from Pfizer, Inc. Dr. Hernandez receives Grant/Research Support; Company Relationship; AstraZeneca, Bristol‐Myers Squibb, GlaxoSmithKline, Luitpold Pharmaceuticals, Merck, Novartis. Honoraria; Company Relationship; Bayer, Boston Scientific, Novartis. Dr. Felker has received research funding from Otsuka, Novartis, Roche Diagnostics, Amgen, Merck, American Heart Association, and the National Heart, Lung, and Blood Institute; and has served as a consultant for Novartis, Roche Diagnostics, Amgen, Trevena, Cytokinetics, Madeliene, Myokardia, Bristol‐Myers Squibb, Stealth Biotherapeutics, a
nd GlaxoSmithKline. Dr. Mentz receives research support from the National Institutes of Health (U01HL125511‐01A1, U10HL110312, and R01AG045551‐01A1), Akros, Amgen, AstraZeneca, Bayer, GlaxoSmithKline, Gilead, Luitpold, Medtronic, Merck, Novartis, Otsuka, and ResMed; honoraria from Abbott, AstraZeneca, Bayer, Janssen, Luitpold Pharmaceuticals, Medtronic, Merck, Novartis, and ResMed; and has served on an advisory board for Amgen, Luitpold, Merck, and Boehringer Ingelheim. The remaining authors have no disclosures to report.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material content-type="local-data" id="JAH35769-sup-0001">
                <caption>
                  <p>
                    <bold>Table S1–S2</bold>
                  </p>
                </caption>
                <media xlink:href="JAH3-9-e015752-s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ref-list content-type="cited-references" id="jah35769-bibl-0001">
              <title>REFERENCES</title>
              <ref id="jah35769-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="journal" id="jah35769-cit-0001"><string-name><surname>Bart</surname><given-names>BA</given-names></string-name>, <string-name><surname>Goldsmith</surname><given-names>SR</given-names></string-name>, <string-name><surname>Lee</surname><given-names>KL</given-names></string-name>, <string-name><surname>Givertz</surname><given-names>MM</given-names></string-name>, <string-name><surname>O'Connor</surname><given-names>CM</given-names></string-name>, <string-name><surname>Bull</surname><given-names>DA</given-names></string-name>, <string-name><surname>Redfield</surname><given-names>MM</given-names></string-name>, <string-name><surname>Deswal</surname><given-names>A</given-names></string-name>, <string-name><surname>Rouleau</surname><given-names>JL</given-names></string-name>, <string-name><surname>LeWinter</surname><given-names>MM</given-names></string-name>, et al. <article-title>Ultrafiltration in decompensated heart failure with cardiorenal syndrome</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2012</year>;<volume>367</volume>:<fpage>2296</fpage>–<lpage>2304</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1210357</pub-id>.<pub-id pub-id-type="pmid">23131078</pub-id></mixed-citation>
              </ref>
              <ref id="jah35769-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="jah35769-cit-0002"><string-name><surname>Costanzo</surname><given-names>MR</given-names></string-name>, <string-name><surname>Negoianu</surname><given-names>D</given-names></string-name>, <string-name><surname>Jaski</surname><given-names>BE</given-names></string-name>, <string-name><surname>Bart</surname><given-names>BA</given-names></string-name>, <string-name><surname>Heywood</surname><given-names>JT</given-names></string-name>, <string-name><surname>Anand</surname><given-names>IS</given-names></string-name>, <string-name><surname>Smelser</surname><given-names>JM</given-names></string-name>, <string-name><surname>Kaneshige</surname><given-names>AM</given-names></string-name>, <string-name><surname>Chomsky</surname><given-names>DB</given-names></string-name>, <string-name><surname>Adler</surname><given-names>ED</given-names></string-name>, et al. <article-title>Aquapheresis versus intravenous diuretics and hospitalizations for heart failure</article-title>. <source xml:lang="en">JACC Heart Fail</source>. <year>2016</year>;<volume>4</volume>:<fpage>95</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.jchf.2015.08.005</pub-id>.<pub-id pub-id-type="pmid">26519995</pub-id></mixed-citation>
              </ref>
              <ref id="jah35769-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal" id="jah35769-cit-0003"><string-name><surname>Costanzo</surname><given-names>MR</given-names></string-name>, <string-name><surname>Guglin</surname><given-names>ME</given-names></string-name>, <string-name><surname>Saltzberg</surname><given-names>MT</given-names></string-name>, <string-name><surname>Jessup</surname><given-names>ML</given-names></string-name>, <string-name><surname>Bart</surname><given-names>BA</given-names></string-name>, <string-name><surname>Teerlink</surname><given-names>JR</given-names></string-name>, <string-name><surname>Jaski</surname><given-names>BE</given-names></string-name>, <string-name><surname>Fang</surname><given-names>JC</given-names></string-name>, <string-name><surname>Feller</surname><given-names>ED</given-names></string-name>, <string-name><surname>Haas</surname><given-names>GJ</given-names></string-name>, et al. <article-title>Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure</article-title>. <source xml:lang="en">J Am Coll Cardiol</source>. <year>2007</year>;<volume>49</volume>:<fpage>675</fpage>–<lpage>683</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2006.07.073</pub-id>.<pub-id pub-id-type="pmid">17291932</pub-id></mixed-citation>
              </ref>
              <ref id="jah35769-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="journal" id="jah35769-cit-0004"><string-name><surname>Fudim</surname><given-names>M</given-names></string-name>, <string-name><surname>Hernandez</surname><given-names>AF</given-names></string-name>, <string-name><surname>Felker</surname><given-names>GM</given-names></string-name>. <article-title>Role of volume redistribution in the congestion of heart failure</article-title>. <source xml:lang="en">J Am Heart Assoc</source>. <year>2017</year>;<volume>6</volume>:<elocation-id>e006817</elocation-id>. DOI: <pub-id pub-id-type="doi">10.1161/JAHA.117.006817</pub-id>.<pub-id pub-id-type="pmid">28862947</pub-id></mixed-citation>
              </ref>
              <ref id="jah35769-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="jah35769-cit-0005"><string-name><surname>Fudim</surname><given-names>M</given-names></string-name>, <string-name><surname>Grodin</surname><given-names>JL</given-names></string-name>, <string-name><surname>Mentz</surname><given-names>RJ</given-names></string-name>. <article-title>Hyperkalemia in heart failure: probably not O"K"</article-title>. <source xml:lang="en">J Am Heart Assoc</source>. <year>2018</year>;<volume>7</volume>:<elocation-id>e009429</elocation-id>. <pub-id pub-id-type="doi">10.1161/JAHA.118.009429</pub-id>.<pub-id pub-id-type="pmid">29789333</pub-id></mixed-citation>
              </ref>
              <ref id="jah35769-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="jah35769-cit-0006"><string-name><surname>Fudim</surname><given-names>M</given-names></string-name>, <string-name><surname>Jones</surname><given-names>WS</given-names></string-name>, <string-name><surname>Boortz‐Marx</surname><given-names>RL</given-names></string-name>, <string-name><surname>Ganesh</surname><given-names>A</given-names></string-name>, <string-name><surname>Green</surname><given-names>CL</given-names></string-name>, <string-name><surname>Hernandez</surname><given-names>AF</given-names></string-name>, <string-name><surname>Patel</surname><given-names>MR</given-names></string-name>. <article-title>Splanchnic nerve block for acute heart failure</article-title>. <source xml:lang="en">Circulation</source>. <year>2018</year>;<volume>138</volume>:<fpage>951</fpage>–<lpage>953</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.118.035260</pub-id>.<pub-id pub-id-type="pmid">29804067</pub-id></mixed-citation>
              </ref>
              <ref id="jah35769-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="jah35769-cit-0007"><string-name><surname>Miller</surname><given-names>WL</given-names></string-name>, <string-name><surname>Mullan</surname><given-names>BP</given-names></string-name>. <article-title>Volume overload profiles in patients with preserved and reduced ejection fraction chronic heart failure: Are there differences? A pilot study</article-title>. <source xml:lang="en">JACC Heart Fail</source>. <year>2016</year>;<volume>4</volume>:<fpage>453</fpage>–<lpage>459</lpage>. DOI:<pub-id pub-id-type="doi">10.1016/j.jchf.2016.01.005</pub-id>.<pub-id pub-id-type="pmid">26970830</pub-id></mixed-citation>
              </ref>
              <ref id="jah35769-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="jah35769-cit-0008"><string-name><surname>Grodin</surname><given-names>JL</given-names></string-name>, <string-name><surname>Carter</surname><given-names>S</given-names></string-name>, <string-name><surname>Bart</surname><given-names>BA</given-names></string-name>, <string-name><surname>Goldsmith</surname><given-names>SR</given-names></string-name>, <string-name><surname>Drazner</surname><given-names>MH</given-names></string-name>, <string-name><surname>Tang</surname><given-names>WHW</given-names></string-name>. <article-title>Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per‐protocol analysis of CARRESS‐HF</article-title>. <source xml:lang="en">Eur J Heart Fail</source>. <year>2018</year>;<volume>20</volume>:<fpage>1148</fpage>–<lpage>1156</lpage>. <pub-id pub-id-type="doi">10.1002/ejhf.1158</pub-id>.<pub-id pub-id-type="pmid">29493059</pub-id></mixed-citation>
              </ref>
              <ref id="jah35769-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="jah35769-cit-0009"><string-name><surname>Marenzi</surname><given-names>G</given-names></string-name>, <string-name><surname>Grazi</surname><given-names>S</given-names></string-name>, <string-name><surname>Giraldi</surname><given-names>F</given-names></string-name>, <string-name><surname>Lauri</surname><given-names>G</given-names></string-name>, <string-name><surname>Perego</surname><given-names>G</given-names></string-name>, <string-name><surname>Guazzi</surname><given-names>M</given-names></string-name>, <string-name><surname>Salvioni</surname><given-names>A</given-names></string-name>, <string-name><surname>Guazzi</surname><given-names>MD</given-names></string-name>. <article-title>Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration</article-title>. <source xml:lang="en">Am J Med</source>. <year>1993</year>;<volume>94</volume>:<fpage>49</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/0002-9343(93)90119-A</pub-id>.<pub-id pub-id-type="pmid">8420299</pub-id></mixed-citation>
              </ref>
              <ref id="jah35769-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="jah35769-cit-0010"><string-name><surname>Chaudhry</surname><given-names>SI</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Concato</surname><given-names>J</given-names></string-name>, <string-name><surname>Gill</surname><given-names>TM</given-names></string-name>, <string-name><surname>Krumholz</surname><given-names>HM</given-names></string-name>. <article-title>Patterns of weight change preceding hospitalization for heart failure</article-title>. <source xml:lang="en">Circulation</source>. <year>2007</year>;<volume>116</volume>:<fpage>1549</fpage>–<lpage>1554</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.107.690768</pub-id>.<pub-id pub-id-type="pmid">17846286</pub-id></mixed-citation>
              </ref>
              <ref id="jah35769-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="jah35769-cit-0011"><string-name><surname>Burkhoff</surname><given-names>D</given-names></string-name>, <string-name><surname>Tyberg</surname><given-names>JV</given-names></string-name>. <article-title>Why does pulmonary venous pressure rise after onset of LV dysfunction: a theoretical analysis</article-title>. <source xml:lang="en">Am J Physiol</source>. <year>1993</year>;<volume>265</volume>:<fpage>H1819</fpage>–<lpage>H1828</lpage>. DOI:<pub-id pub-id-type="doi">10.1152/ajpheart.1993.265.5.H1819</pub-id>.<pub-id pub-id-type="pmid">8238596</pub-id></mixed-citation>
              </ref>
              <ref id="jah35769-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal" id="jah35769-cit-0012"><string-name><surname>Fallick</surname><given-names>C</given-names></string-name>, <string-name><surname>Sobotka</surname><given-names>PA</given-names></string-name>, <string-name><surname>Dunlap</surname><given-names>ME</given-names></string-name>. <article-title>Sympathetically mediated changes in capacitance: redistribution of the venous reservoir as a cause of decompensation</article-title>. <source xml:lang="en">Circ Heart Fail</source>. <year>2011</year>;<volume>4</volume>:<fpage>669</fpage>–<lpage>675</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCHEARTFAILURE.111.961789</pub-id>.<pub-id pub-id-type="pmid">21934091</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
